Press release
Immune-Mediated Inflammatory Diseases Market Key Players Analysis- Novartis AG (Switzerland), Daiichi Sankyo Company, Limited (Japan), Pfizer Inc. (U.S.)
Immune-Mediated Inflammatory Diseases Market
According to the latest research by InsightAce Analytic, the Immune-Mediated Inflammatory Diseases Market is predicted to grow with a CAGR of 7.10% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2889
Immune-mediated inflammatory diseases (IMIDs) encompass a group of related conditions characterized by a shared inflammatory mechanism that induces inflammation, although their etiology remains unclear. These disorders are a result of an overactive or dysfunctional immune system. All IMIDs are associated with increased rates of morbidity and mortality, along with a heightened risk of organ damage. The global prevalence of autoimmune diseases has been steadily increasing, with many of these conditions linked to factors such as poor lifestyle choices, unhealthy dietary habits, and genetic predispositions. As the incidence of these disorders rises, the global market for immune-mediated inflammatory diseases continues to expand. The growing frequency of autoimmune diseases worldwide further accelerates the demand for treatments and solutions within this market.
List of Prominent Players in the Immune-Mediated Inflammatory Diseases Market:
• Novartis AG
• Daiichi Sankyo Company, Limited
• Pfizer Inc.
• Abbvie Inc.
• Merck & Co Inc.
• Zydus Group
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceuticals Industries Ltd.
• Amgen Inc.
• Boehringer Ingelheim International GmbH.
• AstraZeneca
• Ampio Pharmaceuticals Inc.
• Eli Lilly
• Akorn Incorporated
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Market Dynamics:
Drivers:
The global market for immune-mediated inflammatory diseases (IMIDs) is poised for growth due to the rising prevalence of conditions such as psoriasis, Crohn's disease, and rheumatoid arthritis. The expansion of this market is also fueled by the increasing adoption of innovative and targeted biologic therapies for treating these disorders. Furthermore, the market is set to benefit from the growing availability of treatment options through an expanding network of clinics, pharmacies, and online platforms offering solutions for immune-mediated inflammatory diseases.
Challenges:
The market's growth could be hindered by a shortage of skilled healthcare professionals capable of administering advanced treatments. Additionally, the adverse side effects of certain therapies, including skin rashes and complications from immunosuppressive drugs, present a challenge to market expansion. The COVID-19 pandemic further exacerbated these issues, as many countries temporarily halted non-emergency surgeries and reallocated medical resources to combat the pandemic, leading to a significant downturn in the market during that period.
Regional Trends:
The North American market for immune-mediated inflammatory diseases is expected to hold a substantial share in terms of revenue. Factors contributing to this growth include the increasing incidence of autoimmune disorders, the rising demand for targeted biologic therapies, and an enhanced focus on innovative treatments. The approval of new therapies and a growing need for immunosuppressants in the region are also expected to drive market growth. In addition, the Asia-Pacific region is experiencing notable market growth, supported by increasing awareness of treatment options, the growing prevalence of autoimmune diseases, and advancements in medical technologies aimed at treating immune-mediated inflammatory conditions.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2889
Recent Developments:
• In July 2024, AbbVie announced that the European Commission has sanctioned SKYRIZI® (risankizumab) for the treatment of elderly individuals with moderately to severely active ulcerative colitis (UC) who have experienced an inadequate response to, lost response to, or exhibited intolerance to conventional or biologic therapies.
Segmentation of Immune-Mediated Inflammatory Diseases Market-
By Indication-
• Asthma,
• Chronic Obstructive Pulmonary Diseases (COPD)
• Inflammatory Bowel Disease (IBD)
• Systemic Lupus Erythematosus (SLE)
• Rheumatoid Arthritis (RA)
• Psoriasis
• Others
By Treatment Type-
• Traditional Drugs
• Biologic Therapies
• Novel Therapies
By Route of Administration-
• Oral
• Parenteral
• Others
By End-Users-
• Hospitals
• Specialty Clinics
• Others
By Distribution Channel-
• Hospital Pharmacy
• Retail Pharmacy
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/immune-mediated-inflammatory-diseases-market/2889
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immune-Mediated Inflammatory Diseases Market Key Players Analysis- Novartis AG (Switzerland), Daiichi Sankyo Company, Limited (Japan), Pfizer Inc. (U.S.) here
News-ID: 3994598 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
4PL Logistics Market Revenue Report with Forecast to 2034
"4PL Logistics Market" in terms of revenue was estimated to be worth $59.6 Billion in 2024 and is poised to reach $133.3 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1609
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global 4PL Logistics Market are:
• Rapid growth of automotive the…
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Heavy-Duty Autonomous Vehicle Market- (By Application (Logistics, Public Transportation, Construction and Mining, Others), By Propulsion Type (Internal Combustion Engine Vehicles, Electric Vehicles), By Vehicle Type (Heavy Trucks, Heavy Buses, Roboshuttles), By Level of Autonomy (Fully Autonomous Vehicles, Semi-Autonomous Vehicles), By Sensor Type (LiDAR, RADAR, Camera, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034"
The global e-commerce logistics market is estimated to reach over USD 5340.2 billion by 2034, exhibiting a CAGR of 26.4% during the forecast period.
Request For Free Sample Pages:…
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-bikes Market Size, Share & Trends Analysis Report By Class (Class-I, Class-II, Class-III), Speed (Up to 25km/h, 25-45 km/h), Battery Type (Lithium-ion, Lithium-ion Polymer, Lead Acid), Mode (Pedal Assist, Throttle), Component (batteries, electric motors, frames with forks, wheels, crank gears, brake systems and motor controllers) , Motor Type (hub and mid), Usage (mountain, trekking, city/urban,…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
